Literature DB >> 3337842

Phosphorylation of multiple sites in a 15,000 dalton proteolipid from rat skeletal muscle sarcolemma, catalyzed by adenosine 3',5'-monophosphate-dependent and calcium/phospholipid-dependent protein kinases.

S I Walaas1, R S Horn, K A Albert, A Adler, O Walaas.   

Abstract

This study reports a partial characterization of a 15,000 dalton (15 kDa) proteolipid present in rat skeletal muscle sarcolemma. The proteolipid is phosphorylated by both cyclic AMP-dependent and calcium/phospholipid-dependent protein kinases, displays an isoelectric point (pI) of 5.9, and can be extracted from sarcolemma by acidified chloroform/methanol (2:1) or non-ionic detergents. Phosphoamino acid analysis and tryptic fingerprinting of the phosphorylated proteolipid indicate that both cyclic AMP- and calcium/phospholipid-dependent protein kinases predominantly phosphorylate serine residue(s) on a single tryptic peptide. Additivity experiments and thermolytic fingerprinting demonstrate a minimum of two distinct phosphorylation sites on the proteolipid, the phosphorylation of which is independently catalyzed by cyclic AMP-dependent and calcium/phospholipid-dependent protein kinases in vitro. This sarcolemma proteolipid, which appears to be identified to a sarcolemma protein previously reported to be phosphorylated upon addition of insulin in a GTP-dependent manner (Walaas, O., Walaas, E., Rye-Alertsen, A. and Horn, R.S. (1979) Mol. Cell. Endocrinol. 16, 45-55), therefore represents a possible membrane target for those neuronal and hormonal stimuli which can regulate cyclic AMP-dependent or calcium/phospholipid-dependent protein kinase activities in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337842     DOI: 10.1016/0167-4889(88)90052-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Identification of a cytoskeleton-bound form of phospholemman with unique C-terminal immunoreactivity.

Authors:  C E Kelly; M L Ram; S A Francis; T D Houle; S E Cala
Journal:  J Membr Biol       Date:  2004-12       Impact factor: 1.843

2.  Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase.

Authors:  Neeraj Kumar Mishra; Michael Habeck; Corinna Kirchner; Haim Haviv; Yoav Peleg; Miriam Eisenstein; Hans Juergen Apell; Steven J D Karlish
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

3.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.

Authors:  A D Baron; J S Zhu; J H Zhu; H Weldon; L Maianu; W T Garvey
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Brain region-specific expression of Fxyd1, an Mecp2 target gene, is regulated by epigenetic mechanisms.

Authors:  Fatima Banine; Valerie Matagne; Larry S Sherman; Sergio R Ojeda
Journal:  J Neurosci Res       Date:  2011-03-10       Impact factor: 4.164

5.  Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.

Authors:  Valerie Matagne; Joyce Wondolowski; Matthew Frerking; Mohammad Shahidullah; Nicholas A Delamere; Ursula S Sandau; Sarojini Budden; Sergio R Ojeda
Journal:  Brain Res       Date:  2018-06-12       Impact factor: 3.252

6.  Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain.

Authors:  S I Walaas; A J Czernik; O K Olstad; K Sletten; O Walaas
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

7.  Phospholemman, a single-span membrane protein, is an accessory protein of Na,K-ATPase in cerebellum and choroid plexus.

Authors:  Marina S Feschenko; Claudia Donnet; Randall K Wetzel; Natalya K Asinovski; Larry R Jones; Kathleen J Sweadner
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 8.  CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors.

Authors:  Emmanuel Camors; Héctor H Valdivia
Journal:  Front Pharmacol       Date:  2014-05-08       Impact factor: 5.810

9.  Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues.

Authors:  Mariella Cuomo; Ermanno Florio; Rosa Della Monica; Davide Costabile; Michela Buonaiuto; Teodolinda Di Risi; Giulia De Riso; Antonella Sarnataro; Sergio Cocozza; Roberta Visconti; Lorenzo Chiariotti
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.